Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9244 USD | -3.50% | -10.25% | -33.97% |
May. 09 | Oppenheimer Adjusts Seres Therapeutics Price Target to $4 From $5, Maintains Outperform Rating | MT |
May. 09 | Chardan Adjusts Price Target on Seres Therapeutics to $6 From $8, Keeps Buy Rating | MT |
Financials (USD)
Sales 2024 * | 73K | Sales 2025 * | 4.5M | Capitalization | 140M |
---|---|---|---|---|---|
Net income 2024 * | -164M | Net income 2025 * | -153M | EV / Sales 2024 * | 3,645 x |
Net Debt 2024 * | 126M | Net Debt 2025 * | 193M | EV / Sales 2025 * | 74.1 x |
P/E ratio 2024 * |
-0.9
x | P/E ratio 2025 * |
-1.3
x | Employees | 233 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.3% |
Latest transcript on Seres Therapeutics, Inc.
1 day | -3.50% | ||
1 week | -10.25% | ||
Current month | -6.68% | ||
1 month | +45.32% | ||
3 months | -11.96% | ||
6 months | -20.31% | ||
Current year | -33.97% |
Managers | Title | Age | Since |
---|---|---|---|
Eric Shaff
CEO | Chief Executive Officer | 48 | 14-10-31 |
David Ege
CTO | Chief Tech/Sci/R&D Officer | 50 | 20-10-21 |
Chief Tech/Sci/R&D Officer | - | 15-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Ausiello
BRD | Director/Board Member | 78 | 15-03-31 |
Director/Board Member | 68 | 23-01-03 | |
Richard Kender
BRD | Director/Board Member | 68 | 14-10-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 0 M€ | 0.00% | - | |
0.06% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0.00% | - | |
0.03% | 234 M€ | +6.34% | - | |
0.02% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 0.9244 | -3.50% | 2,697,083 |
24-05-15 | 0.9579 | +6.92% | 3,534,433 |
24-05-14 | 0.8959 | -7.17% | 3,901,308 |
24-05-13 | 0.9651 | -5.38% | 3,464,670 |
24-05-10 | 1.02 | -0.97% | 3,874,539 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.97% | 145M | |
+8.29% | 113B | |
+10.21% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.17% | 17.24B | |
+7.70% | 14.29B | |
+37.65% | 12.52B |
- Stock Market
- Equities
- MCRB Stock